Intelligent design
of living systems
Platform
Asimov builds tools to program living cells.
Our mammalian cell engineering platform advances the design and manufacture of biologics and gene therapies.
- 1Chassis: CGMP engineered host cell lines for improved biologics and viral vector manufacturing.
- +2Genetic parts: High-performance vectors and characterized parts libraries for custom functionality.
- +3Kernel: Software for computer-aided cell design, simulation, and multi-omics analysis.
Contact us to learn more.
Focus Areas
Synthetic biology is ushering in an era where therapeutics can be iteratively engineered rather than discovered. Our platform enables an engineering mindset for next-generation medicines.
Monoclonal antibody
manufacturing
Multifunctional and
difficult-to-express
molecule manufacturing
Design of vector payloads
and capsid-specific
optimization
AAV and lentiviral
manufacturing
Technology
Full-stack bioengineering.
Synthetic Biology
Nature has evolved billions of useful molecular devices in the form of genes, across the tree of life. We source, catalog, refine, and remix these genetic components to build new biological systems.
Computer-Aided Design
Biology is complex, and genetic engineering unlocks an unbounded design space. Computational modeling is critical to move synthetic biology beyond traditional brute force screening.
Multi-omics Measurement
Genome-scale, multi-omics measurement technologies provide deep views into the cell. These techniques permit pathway analysis at the scale of a whole cell, and inspection down at single-nucleotide resolution.
Machine Learning
Machine learning bridges large-scale datasets with mechanistic models of biology. Artificial intelligence can augment human capabilities to design and understand biological complexity.
Asimov Inside
We endeavor to build the genetic programs powering the world's most impactful biotechnologies. One day, entire genomes will be designed from the ground up. Come help us build this future.
Meet Our Team
Ours is a culture of recombination, where diverse expertise and experiences intermix. Our team spans synthetic biology, machine learning, computational biology, and automation.
Liza Antonelli
Research Technician
Rachel Bozadjian
Research Associate
Michelle Chang
Synthetic Biologist II
Haewon Chung
Synthetic Biologist II
Amber Delhagen
Senior Research Associate
Douglas Densmore
Co-Founder
Nick Emery
Automation Engineer II
Alina Ferdman
Senior Software Engineer
Jamie Freeman
Director of Business Development and Commercial Strategy
Jeremy Gam
Senior Synthetic Biologist
Brianna Jayanthi
Synthetic Biologist
Maya Kaul
Research Associate
Rachel Kelemen
Synthetic Biologist
Michael Leonard
Associate Synthetic Biologist
Kevin LeShane
Head of Software Design
Alec Nielsen
Co-Founder & CEO
Dan Phelps
Senior Software Engineer
Jessica Rock
Laboratory Operations Manager
Felicity Rudge
Senior Business Development Manager
Dylan Samperi
Automation Engineer
Raja Srinivas
Co-Founder
Christopher Stach
Synthetic Biologist II
Mark Stockdale
Strategic Alliance Director
Susanne Talbot
Talent Acquisition Specialist
David Tulga
Senior Automation Engineer
Drew Ward
Senior Director of Strategic Business Development
Dinghai Zheng
Senior Computational Biologist
Christopher Voigt
Co-Founder
James Collins
Scientific Advisor
Aviv Regev
Scientific Advisor
Investors
We are backed by exceptional investors at the intersection of biology, computation, and engineering.
Grow With Us
If you share our drive to design living systems, we’re interested in hearing from you.
Join usNews
Featured In
Address
1325 Boylston Street,
Suite 500
Boston, MA 02215